HIV, TB and Malaria Programme

Kenya has been a pacesetter in health innovations and has had great success in putting people on HIV treatment, hitting the 1 million mark in 2017, up from 98,000 in 2006. Community-based programming, bilateral and multi-sector partnerships and an active civil society movement has helped bolster the response to HIV, tuberculosis and malaria.

Despite the progress, Kenya still faces challenges in the response to HIV, TB and malaria, and in building resilient and sustainable systems for health. Kenya is one of the countries in the world faced with the double burden of HIV and TB. With 1.5 million people living with HIV in the country, Kenya has the fourth-largest HIV epidemic in the world. At about 78,000, the number of new HIV infections per year remains high. As for TB, the country is one of the 30 high-burden countries that together account for more than 80 percent of the world’s TB cases. Drug-resistant TB remains a big challenge in the country. Malaria remains a major cause of sickness and death, with more than 70 percent of the population at risk of the disease.

To ensure sustainable and better health outcomes in the prevention, management and treatment of TB, HIV, malaria and non-communicable diseases, Amref Health Africa implements innovative, scalable and practical solutions that seek to: